• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

    PRESS RELEASE

    AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9

    GLOBENEWSWIRE

    AFFiRiS presents positive preclinical in vivo data with antibody mAB C6-17

    PHARMABIZ

    Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17

    PRESS RELEASE

    AFFiRiS Announces FDA to its pre-IND Sub for Phase 2 trial with AFFITOPE PD01

    FINANCE YAHOO

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.